Usage jumps to 43% among people diagnosed with type 2 diabetes and 22% of those told by a doctor that theyre overweight or obese
Donald Rucker breaks down what the proposed rule actually changes: FHIR protocol requirements shifting from advisory to mandatory, prior authorization extending to drugs across two parallel pathways (Da Vinci FHIR for medical benefit drugs, NCPDP for pharmacy benefit), and a new National Healthcare Directory reporting requirement that gives CMS a practical compliance enforcement mechanism for the first time
Semaglutide works by mimicking the GLP-1 hormone that signals fullness to the brain
Spacing meals appropriately allows adequate digestion time, though this should be individualised to your treatment goals and comfort
It reduces blood glucose by simultaneously stimulating insulin secretion, which is why it is effective in Type II and not Type I diabetes, and lowers glucagon secretion
however, they differ in how they approach medications, personalization, and their care structures
